Stock Earnings Potential Price Increase for Entrada Therapeutics Inc (TRDA) After Recent Insider Activity Entrada Therapeutics Inc’s recently made public that its Director PARMAR KUSH unloaded Company’s shares for reported $0.2 million on Jul
Insiders Updates The Attractiveness of Investing In Entrada Therapeutics Inc (TRDA) is Growing Entrada Therapeutics Inc’s filing revealed that its Director PARMAR KUSH unloaded Company’s shares for reported $0.52 million on Jun 27